IL6 and cardiovascular disorder: An increased expression of the fibrinolysis inhibitor serpine-1 (PAI-1) and Interleukin-6 (IL-6) indicated a pro-inflammatory milieu, especially in the vascular system, a phenomenon linked to aging-related cardiovascular pathologies [40].